Showing results (511-520 of 16,802) with videos related to
Sort By:
Pageof 1,681
British Journal of Haematology|January 14, 1999
The impact of antenatal and perinatal variables on cord blood haemopoietic stem/progenitor cell yield available for transplantationA A Shlebak, I A Roberts, T A Stevens, et al.British Journal of Haematology|January 14, 1999
Mobilization of primitive haemopoietic progenitor cells and stem cells with long-term repopulating ability into peripheral blood in mice by pegylated recombinant human megakaryocyte growth and development factorY Torii, Y Nitta, H Akahori, et al.British Journal of Haematology|January 10, 2006
Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchangeB F Wyllie, A X Garg, J Macnab, et al.British Journal of Haematology|January 10, 2006
Dual gene defects involving delta-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patientReiko Akagi, Rikako Inoue, Shikibu Muranaka, et al.British Journal of Haematology|January 18, 2006
Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndromeJamie Robyn, Steven Lemery, J Philip McCoy, et al.British Journal of Haematology|January 18, 2006
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal stateAnders Dahm, Frits R Rosendaal, Trine O Andersen, et al.British Journal of Haematology|January 18, 2006
Bacitracin reveals a role for multiple thiol isomerases in platelet functionAisling Robinson, Sarah O'Neill, Aoife Kiernan, et al.British Journal of Haematology|January 18, 2006
Impaired interaction of alpha-haemoglobin-stabilising protein with alpha-globin termination mutant in a yeast two-hybrid systemChairat Turbpaiboon, Thawornchai Limjindaporn, Wiyada Wongwiwat, et al.British Journal of Haematology|January 18, 2006
HLA-DRB1 polymorphism is associated with Kell immunisationJacques Chiaroni, Isabelle Dettori, Virginie Ferrera, et al.British Journal of Haematology|February 19, 2002
Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patientsKarin Karlsson, Mats Strömberg, Jan Liliemark, et al.Pageof 1,681